Patel Saumil, Patel Pinakin, Jiyani Rucha, Ghosh Sudeshna, Patel Divyank
Anesthesiology, M P Shah Medical College, Jamnagar, IND.
Gastroenterology, Bombay Hospital and Medical Research Centre, Mumbai, IND.
Cureus. 2020 Sep 14;12(9):e10454. doi: 10.7759/cureus.10454.
The association between hepatitis C virus (HCV) and sarcoidosis is well-documented, but in this case report, we shall discuss an interesting association between hepatitis B virus (HBV) and sarcoidosis, presenting with non-specific symptoms and confirmed with liver biopsy and immunologic markers. The case was complicated by treatment with immunosuppressive medication that led to colonic histoplasmosis. A 58-year-old woman, from the western part of India, who has a past medical history of HBV-related cirrhosis of the liver for six months, hypertension, and type 2 diabetes presented to our clinic with bilateral pedal edema, anorexia, and mild epigastric discomfort. She had been on entecavir for the last six months. The patient denied any significant surgical, social, or family history. Abdominal ultrasonography revealed hepatosplenomegaly and mesenteric lymphadenopathy. She had a 21.3kPa liver stiffness on elastography and an HBV deoxyribonucleic acid (DNA) level of 89 copies/ml. Liver biopsy showed multiple noncaseating granulomas consisting of Langerhans cells in the parenchyma and portal tract, associated with moderate inflammation. A chest computed tomography (CT) scan showed upper and middle lobe fibrosis of the lungs; this diagnosis was further confirmed with elevated angiotensin-converting enzymes. She was started on prednisone; within a period of three months, she experienced weight loss, diarrhea, and fever. Colonoscopy was done after an abdomen CT showed mural thickening of the ascending colon and terminal ileum, which on biopsy was confirmed as histoplasmosis. Prednisone was stopped, and the patient was treated with hydroxychloroquine and amphotericin B, followed by itraconazole. The patient improved symptomatically, and repeated colonoscopy findings were normal. Studies are scarce to prove the association between hepatitis B and sarcoidosis; however, we reasonably hypothesized that the alterations in the pool of cytokines and immune cells caused by HBV infection might have had a vicious influence on immune regulation and could be a trigger for granuloma. Further studies can impact the future to provide for a better understanding of the pathophysiology of sarcoidosis, HBV correlation, and treatment options.
丙型肝炎病毒(HCV)与结节病之间的关联已有充分记录,但在本病例报告中,我们将讨论乙型肝炎病毒(HBV)与结节病之间一个有趣的关联,该病例表现为非特异性症状,并经肝活检和免疫标志物确诊。该病例因使用免疫抑制药物治疗而并发结肠组织胞浆菌病。一名来自印度西部的58岁女性,有6个月的HBV相关性肝硬化病史、高血压和2型糖尿病史,因双侧足部水肿、厌食和轻度上腹部不适前来我院就诊。她在过去6个月一直在服用恩替卡韦。患者否认有任何重大手术史、社会史或家族史。腹部超声检查显示肝脾肿大和肠系膜淋巴结肿大。弹性成像显示肝脏硬度为21.3kPa,HBV脱氧核糖核酸(DNA)水平为89拷贝/毫升。肝活检显示实质和门管区有多个由朗汉斯细胞组成的非干酪样肉芽肿,伴有中度炎症。胸部计算机断层扫描(CT)显示肺部上叶和中叶纤维化;血管紧张素转换酶升高进一步证实了这一诊断。她开始服用泼尼松;在三个月内,她出现了体重减轻、腹泻和发热。腹部CT显示升结肠和回肠末端肠壁增厚后进行了结肠镜检查,活检证实为组织胞浆菌病。停用泼尼松,患者接受羟氯喹和两性霉素B治疗,随后使用伊曲康唑。患者症状改善,重复结肠镜检查结果正常。目前缺乏研究来证明乙型肝炎与结节病之间的关联;然而,我们合理推测,HBV感染引起的细胞因子和免疫细胞池的改变可能对免疫调节产生了恶性影响,可能是肉芽肿的触发因素。进一步的研究可能会对未来产生影响,以便更好地理解结节病的病理生理学、HBV相关性及治疗选择。